Mepolizumab in a population with severe osinophilic asthma and corticosteroid dependence: results from French early access programme

Mepolizumab in a population with severe osinophilic asthma and corticosteroid dependence: results from French early access programme

Mepolizumab in a population with severe osinophilic asthma and corticosteroid dependence: results from French early access programme

TAILLE C, CHANEZ P, DEVOUASSOUX G, DIDIER A, PISON C, GARCIA G, CHARRIOT J, BOUEE S, GRUBER A, PRIBIL C, BOURDIN A, HUMBERT M.